Related references
Note: Only part of the references are listed.Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools
S. Salomone et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cells
Dongmei Wang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms
R. Granata et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Functions of the multifaceted family of sphingosine kinases and some close relatives
Sarah Spiegel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Insulin-like growth factors mediate heterotrimeric G protein-dependent ERK1/2 activation by transactivating sphingosine 1-phosphate receptors
Hesham M. El-Shewy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Nonsecreted insulin-like growth factor binding protein-3 (IGFBP-3) can induce apoptosis in human prostate cancer cells by IGF-independent mechanisms without being concentrated in the nucleus
Nisan Bhattacharyya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1
O Sukocheva et al.
JOURNAL OF CELL BIOLOGY (2006)
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages
B Visentin et al.
CANCER CELL (2006)
Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRα/Nur77
KW Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sphingosine 1-phosphate transactivates the platelet-derived growth factor β receptor and epidermal growth factor receptor in vascular smooth muscle cells
T Tanimoto et al.
CIRCULATION RESEARCH (2004)
Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: The role of altered epidermal growth factor signaling
AJ Butt et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Differentially expressed genes in nonsmall cell lung cancer:: expression profiling of cancer-related genes in squamous cell lung cancer
E Kettunen et al.
CANCER GENETICS AND CYTOGENETICS (2004)
Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization: implications for retinoic acid-sensitivity in human breast cancer cells
LJ Schedlich et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase
T Ahmad et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms
DE Hansel et al.
CLINICAL CANCER RESEARCH (2004)
Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-β-induced cell responses
CY Xin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer
J Okami et al.
CANCER RESEARCH (2004)
Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720
ML Allende et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: Involvement of the sphingolipid signaling pathways
R Granata et al.
FASEB JOURNAL (2004)
Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation
SM Pitson et al.
EMBO JOURNAL (2003)
Sphingosine kinase transmits estrogen signaling in human breast cancer cells
OA Sukocheva et al.
MOLECULAR ENDOCRINOLOGY (2003)
Sphingosine-1-phosphate: An enigmatic signalling lipid
S Spiegel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Overexpression of KIT in chromophobe renal cell carcinoma
K Yamazaki et al.
ONCOGENE (2003)
Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells - Involvement of p44/42 and p38 mitogen-activated protein kinases
JL Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cellular actions of the insulin-like growth factor binding proteins
SM Firth et al.
ENDOCRINE REVIEWS (2002)
Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin
C McCaig et al.
JOURNAL OF CELL SCIENCE (2002)
IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells
AJ Butt et al.
ENDOCRINOLOGY (2002)
Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis - Correlation of binding affinity with ability to prevent apoptosis
BE Forbes et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Gene expression correlates of clinical prostate cancer behavior
D Singh et al.
CANCER CELL (2002)
Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production
YG Kwon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells
AJ Butt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
An oncogenic role of sphingosine kinase
P Xia et al.
CURRENT BIOLOGY (2000)
Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis
BR Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity
CA Conover et al.
ENDOCRINOLOGY (2000)
Sphingosine 1-phosphate activates Erk-1/-2 by transactivating epidermal growth factor receptor in rat-2 cells
JH Kim et al.
IUBMB LIFE (2000)
Share Paper
